Related Experiment Video
Updated: Jul 1, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Desferrithiocin analogues and nephrotoxicity
Raymond J Bergeron1, Jan Wiegand, James S McManis
1Department of Medicinal Chemistry, University of Florida, Gainesville, Florida 32610-0485, USA. rayb@ufl.edu
Researchers synthesized novel iron-chelating ligands and evaluated their iron-clearing efficiency (ICE). An optimal balance between lipophilicity and ICE was identified, crucial for developing safer iron chelators.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Toxicology
Background:
- Iron overload is a serious condition requiring effective chelation therapy.
- Developing orally active iron chelators with improved safety profiles is a significant challenge.
Purpose of the Study:
- To synthesize and characterize novel 4'-O-alkylated and 5'-O-alkylated dihydroxyphenyl thiazolecarboxylic acid ligands.
- To determine the iron-clearing efficiency (ICE) and pharmacokinetic properties of these ligands.
- To investigate the relationship between lipophilicity, ICE, and potential nephrotoxicity.
Main Methods:
- Synthesis of novel thiazolecarboxylic acid derivatives.
- Determination of partition coefficient (log P(app)) and iron-clearing efficiency (ICE).
- In vivo studies in rodent and primate models to assess biliary ferrokinetics and toxicity.
Main Results:
- Synthesis of two series of 4'-O-alkylated and 5'-O-alkylated ligands.
- Identification of an optimal log P(app)/ICE relationship in rodent models, suggesting a parabolic correlation.
- Data suggests lipophilicity and ICE may contribute to nephrotoxicity in desferrithiocin analogues.
Conclusions:
- Novel iron chelators with varying lipophilicity and ICE were successfully synthesized.
- An optimal lipophilicity range exists for effective iron chelation, balancing efficacy and safety.
- Further investigation is needed to elucidate the mechanisms of nephrotoxicity associated with these chelators.
Related Concept Videos
Inhibitors of Bacterial Protein Synthesis
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antifungal Agents
